Giu (@generosoMD) profile picture

Giu

@generosoMD
 São Paulo, Brasil
Joined July 2009
  • Tweets475
  • Following164
  • Followers696
51Media
Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)Photo by Giu (@generosoMD)
📣: Fueled by ongoing increases in high blood pressure, obesity and other major risk factors, CVD remains leading cause of death as key health risk factors continue to rise The 2025 Statistics Update is now available.
Image from AHA Science (@AHAScience)
3
9
2
12
4,171
#AHA24 Prior studies: ⬆️vol. physical act (PA) linked ⬆️CAC in suggesting early atherosclerosis Our findings: ⬆️Vol. PA was 🚫 linked w/ ⬆️CAC in asympt w/o CVD ELSA-Brasil cohort Longitudinal athlete-level data is lacking Thx my mentor @MBittencourtMD and all ELSA-Brasil
Image from Ronaldo Correa Fabiano (@Ronaldo_CFF)
3
6
27
1,350
❤️‍🔥🩸 ➡️What is the transfusion threshold in AMI with anemia? Happy to share our meta-analysis! #MINT @MBittencourtMD @laramspc @nogueira_alleh @GewehrDM @generosoMD @RCardoso_MD 10.36660/abc.20240158 @ArquivosSBC @CircAHA @SVRaoMD @JDawnAbbott1 @docjohanne @AGoldsweig
Image from Ronaldo Correa Fabiano (@Ronaldo_CFF)
5
11
38
4,448
1/ The 2024 Statistical Update is your comprehensive look at US and global data on heart and brain health, and an analysis of the core behaviors and conditions that affect CVD risk. Get the latest data published in @CIRCAHA: spr.ly/6014nUbzO ✍🏼 @SethShayMartin
Image from AHA Science (@AHAScience)
1
6
1
12
2,855
👏👏👏👏 @MBittencourtMD
SOCESP (@SocCardioESP) profile pictureSOCESP@SocCardioESP31 May 2024
O prof. da Universidade de Pittsburgh, Marcio Bittencourt, é mais um conferencista internacional que veio participar do Congresso da SOCESP. Ele debate o papel da tomografia computadorizada cardíaca e os avanços m relação à doença cardiovascular aterosclerótica em duas palestras.
Image from SOCESP (@SocCardioESP)
Image from SOCESP (@SocCardioESP)
Image from SOCESP (@SocCardioESP)
1
5
152
These 2 weeks have been intensive but rewarding, hope I have contributed with a drop of water on the big ocean of preventive cardiology. Time to implement the knowledge !
Image from Raul Santos (@rauldsf_santos)
Image from Raul Santos (@rauldsf_santos)
Image from Raul Santos (@rauldsf_santos)
Image from Raul Santos (@rauldsf_santos)
1
3
34
1,101
1/ Hypertension, obesity & other risk factors continue to contribute to high rates of heart disease and stroke worldwide, including in the US, where annual CVD deaths are approaching 1M. Get the latest data published in @CIRCAHA: spr.ly/6013nUkLc ✍🏼 @SethShayMartin
Image from AHA Science (@AHAScience)
1
15
26
5,395
1/ In 2021, 1.7M global deaths were attributed to diabetes, according to the 2024 Statistical Update, which also found that newer therapies proven to lower CVD risk remain underused. Get the latest data published in @CIRCAHA: spr.ly/6015nUVdS ✍🏼 @SethShayMartin
Image from AHA Science (@AHAScience)
1
10
24
3,578
Giu retweeted
NEJM (@NEJM) profile picture
NEJM
@NEJM31 Jan 2024
Dengue outbreaks can affect 390 million persons yearly. In a trial involving 16,235 persons in Brazil, the live, attenuated, tetravalent Butantan vaccine was efficacious in all age groups at 2 years. Read the full trial results: nej.md/3vTJ3Qu
Cumulative Incidence of Virologically Confirmed Dengue through 2-Year Follow-Up

ALT Cumulative Incidence of Virologically Confirmed Dengue through 2-Year Follow-Up

13
460
129
1,263
526,935
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM nejm.org/doi/full/10.1056/NE… Proud and inspired by Brazilian scientists and investigators !
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM

Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM

Butantan–Dengue Vaccine (Butantan-DV) is an investigational, single-dose, live, attenuated, tetravalent vaccine against dengue disease, but data on its overall efficacy are needed. In an ongoing ph...

nejm.org
2
14
1,377
LDL-C–Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes | Circulation ahajournals.org/doi/10.1161/… Huge progress how to guarantee access? @dramitkhera @khurramn1
LDL-C–Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia:...

LDL-C–Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia:...

ahajournals.org
3
13
48
3,529
🆕 The 2024 Statistical Update is available now! Heart disease remains the leading cause of death in U.S., yet fewer than half of adults surveyed knew it was their biggest health threat. Get the latest data here: spr.ly/6017TdrOB
Image from AHA Science (@AHAScience)
3
33
7
59
30,873
A diagnostic test can only have clinical implications if it leads to changes in patient management. Our recent meta-analysis shows the changes in medications that occur after cardiac CT. authors.elsevier.com/c/1iTSL…
1
5
21
2,809
Coronary CTA before planned invasive diagnostic cath might be routine for chronic CAD patients. Doing a CTA in patients who would otherwise undergo cath is not only safe but it is also associated with more selective revascularizations and lower stroke rates!
CircImaging (@CircImaging) profile pictureCircImaging@CircImaging22 Nov 2023
#metaanalysis of 5,727 patients with chest pain referred for cath randomized to CCTA vs cath-first. CCTA was linked to lower rates of revasc and stroke compared to cath-first approach #AHAJournals ahajournals.org/doi/10.1161/… @JiwonKimMD
Image from CircImaging (@CircImaging)
2
15
3
61
14,528
#metaanalysis of 5,727 patients with chest pain referred for cath randomized to CCTA vs cath-first. CCTA was linked to lower rates of revasc and stroke compared to cath-first approach #AHAJournals ahajournals.org/doi/10.1161/… @JiwonKimMD
Image from CircImaging (@CircImaging)
11
5
35
22,257
Early identification of oesophageal lesions after atrial fibrillation ablation to prevent atrio-oesophageal fistula academic.oup.com/eurheartj/a… #Epeeps
Image from Mauricio Scanavacca (@Scanav1Mauricio)
Image from Mauricio Scanavacca (@Scanav1Mauricio)
3
24
72
8,620
A very special moment #AHA23, finally met in person most of our #ELSAbrasil team!! @generosoMD @MBittencourtMD @RCardoso_MD @PauloLotufo Dr. Isabela Bensenor
Image from Ronaldo Correa Fabiano (@Ronaldo_CFF)
Image from Ronaldo Correa Fabiano (@Ronaldo_CFF)
Image from Ronaldo Correa Fabiano (@Ronaldo_CFF)
3
1
15
3,301
☝️All patients receiving statins (regardless of dose) should be associated with ezetimibe 👉Low cost 👉No side effects 👉20% LDLc reduction
Image from Pablo Corral MD (@drpablocorral)
23
71
4
296
54,272
Outstanding work on calculated cardiovascular risk in the brazilian population from my friend @fernando_cesena sciencedirect.com/science/ar…
4
7
1,151
🔥Excited to share - Abstract accepted at #AHA2023 #CardioTwitter GlycA predicts CAC incidence and progression ELZA-Brasil cohort Grateful @MBittencourtMD @generosoMD @RCardoso_MD @rauldsf_santos Isabela Bensenor @PauloLotufo Peter Toth Steven R. Jones
Image from Ronaldo Correa Fabiano (@Ronaldo_CFF)
6
7
1
44
6,877
Load more